Key stats
About Evolve Global Healthcare Enhanced Yield Fund
Home page
Inception date
Oct 25, 2017
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Primary advisor
Evolve Funds Group, Inc.
ISIN
CA30051T2002
The fund is a passively managed ETF that provides exposure to 20 of the largest healthcare stocks in developed countries. The fund holds companies identified as Health Technology using FactSets Revere Business Industry Classification System. At any time, the fund manager can write covered call options at its discretion on not more than 33% of its securities, depending on market volatility and other factors. The index is and reviewed quarterly, assigning equal weights for each eligible security.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.81%
Health Technology99.72%
Bonds, Cash & Other0.19%
Cash0.28%
Rights & Warrants−0.08%
Stock breakdown by region
North America69.60%
Europe30.40%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
LIFE.B top holdings are AbbVie, Inc. and Johnson & Johnson, occupying 5.95% and 5.84% of the portfolio correspondingly.
LIFE.B last dividends amounted to 0.23 CAD. The month before, the issuer paid 0.23 CAD in dividends,
LIFE.B assets under management is 32.85 M CAD. It's risen 0.04% over the last month.
LIFE.B fund flows account for −8.67 M CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, LIFE.B pays dividends to its holders with the dividend yield of 12.11%. The last dividend (Oct 8, 2025) amounted to 0.23 CAD. The dividends are paid monthly.
LIFE.B shares are issued by Evolve Funds Group, Inc. under the brand Evolve. The ETF was launched on Oct 25, 2017, and its management style is Passive.
LIFE.B expense ratio is 0.72% meaning you'd have to pay 0.72% of your investment to help manage the fund.
LIFE.B follows the Solactive Global Healthcare 20 Index - CAD. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
LIFE.B invests in stocks.
LIFE.B price has risen by 0.13% over the last month, and its yearly performance shows a −8.29% decrease. See more dynamics on LIFE.B price chart.
NAV returns, another gauge of an ETF dynamics, showed a −0.19% decrease in three-month performance and has decreased by −0.77% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −0.19% decrease in three-month performance and has decreased by −0.77% in a year.
LIFE.B trades at a premium (0.41%) meaning the ETF is trading at a higher price than the calculated NAV.